Your browser doesn't support javascript.
loading
Role of CD44 in tumour progression and strategies for targeting.
Negi, Lalit Mohan; Talegaonkar, Sushama; Jaggi, Manu; Ahmad, Farhan J; Iqbal, Zeenat; Khar, Roop K.
Affiliation
  • Negi LM; Department of Pharmaceutics, Jamia Hamdard, New Delhi, India.
J Drug Target ; 20(7): 561-73, 2012 Aug.
Article in En | MEDLINE | ID: mdl-22758394
ABSTRACT
CD44 or hyaluronan receptor is a transmembrane receptor associated with aggressive tumour growth, proliferation, and metastasis. In normal physiology, this receptor has a crucial role in cell adhesion, inflammation, and repair processes. However, many tumour cells over-express this receptor and abuse it to become progressive and perpetual units. The article comments from common functioning of the CD44 receptor, to its diabolic multi-dimensional effects in promotion of malignant cells. It also illuminates the relations of CD44 endorsed processes with other biomolecular events in cancer progression. In an end, the review focuses comprehensively at ongoing researches to exploit the CD44 over-expression as a probable target in treatment, management, and diagnosis of malignancy.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Hyaluronan Receptors / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Drug Target Journal subject: FARMACOLOGIA Year: 2012 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Hyaluronan Receptors / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Drug Target Journal subject: FARMACOLOGIA Year: 2012 Document type: Article Affiliation country: India